Core Insights - SelectQuote reported a strong quarter driven by effective execution during the Medicare Advantage season, achieving near-record senior EBITDA margins of 39% despite modest year-over-year growth [4][10][24] - The company has made significant advancements in its health care services segment, with revenue increasing by 26% year over year, highlighting the impact of SelectRx on the health and quality of life for seniors [4][25] - Recent changes by a national carrier partner necessitated a reduction in fiscal 2026 guidance, with an expected $20 million impact from both the carrier's marketing budget cuts and PBM reimbursement changes, totaling a $40 million aggregate impact [6][7][30] Financial Performance - SelectQuote's revenue grew by 12% year over year, totaling $537 million, driven by both senior and health care services businesses [22][24] - Senior revenue reached $262 million, growing 2% due to increased approved policy volumes, while adjusted EBITDA for the senior segment was $102 million, consistent with last year's performance [24][31] - The company expects operating cash flow for fiscal 2026 to be between $25 million and $35 million, representing a significant increase compared to the previous year [8][32] Strategic Developments - A multiyear agreement with a key pharmacy benefit manager (PBM) enhances visibility into drug reimbursement pricing, which is crucial for expanding profitability [5][37] - The new $415 million credit facility improves capital flexibility, extending debt maturities to 2031 and allowing the company to pursue growth opportunities strategically [5][29] - SelectQuote's operational model focuses on profitability and cash flow over growth, with a commitment to optimizing customer targeting and capital deployment [21][55] Market Dynamics - The Medicare Advantage market is experiencing disruptions, with a significant number of plans being terminated and changes in policy features, leading to increased consumer engagement [13][17] - SelectQuote's strategy during the AEP focused on retaining tenured agents and proactively connecting with policyholders, resulting in a policy volume growth of 4% [9][10] - The company achieved a recapture rate of 33%, indicating strong customer retention and the effectiveness of its service model in a dynamic market [15][17] Future Outlook - Despite the recent guidance reduction, SelectQuote maintains confidence in its long-term growth, profitability, and cash flow potential, with targets of over 20% EBITDA margins for the senior division and an annualized adjusted EBITDA exit rate of $40 million to $50 million for health care services [31][32] - The company is positioned to capitalize on market opportunities, leveraging its diversified model and operational efficiencies to drive shareholder value [65]

Financial Data and Key Metrics Changes - SelectQuote reported a revenue growth of 12% year-over-year, totaling $537 million, driven by both Senior and Healthcare Services businesses [21] - Senior revenue grew 2% to $262 million, with adjusted EBITDA of $102 million, maintaining near record margins of 39% [22][23] - Healthcare Services revenue increased by 26% year-over-year to $231 million, with membership growing 17% to 113,000 [22][24] - Operating cash flow for fiscal 2026 is expected to be $25 million-$35 million, representing a significant increase compared to the previous year [29][31] Business Line Data and Key Metrics Changes - The Senior division achieved an EBITDA margin of 39%, marking the fourth consecutive AEP season above 30% [10][22] - Healthcare Services segment revenue growth of 26% year-over-year reflects strong demand for SelectRx services [5][24] - Life insurance revenue grew 9% to $44 million, driven by a strong quarter for final expense, while term Life business remained flat [24] Market Data and Key Metrics Changes - The Medicare Advantage market experienced significant disruptions, with approximately 7% of plans canceled by carriers, compared to a historical average below 1% [13][14] - SelectQuote's recapture rate improved to 33%, indicating strong customer retention amidst market volatility [15] Company Strategy and Development Direction - SelectQuote's strategy focuses on agent retention and proactive engagement with policyholders to navigate market disruptions [10][15] - The company aims to prioritize profitability and cash flow over growth, leveraging its diversified model to capitalize on market opportunities [20][54] - A new $415 million credit facility enhances capital flexibility, allowing the company to invest strategically while managing debt maturities [7][26] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the long-term growth, profitability, and cash flow potential despite recent headwinds impacting fiscal 2026 guidance [8][28] - The company remains committed to providing high-quality service to beneficiaries, which is increasingly valuable in a challenging market environment [17][54] Other Important Information - SelectQuote entered a multi-year agreement with a pharmacy benefit manager (PBM), improving visibility into drug reimbursement pricing [6][34] - The company anticipates a $40 million aggregate impact on fiscal 2026 guidance due to changes in PBM reimbursement and a national carrier's marketing budget cuts [7][28] Q&A Session Summary Question: Details on the PBM deal and its impact - Management confirmed that the new PBM arrangement provides stability and predictability, addressing the $20 million hit in fiscal 2026 as a one-time issue [34][35] Question: Risks of other carriers following the marketing budget cuts - Management indicated that the decision to cut marketing budgets was not unique to SelectQuote and expressed confidence in navigating through these challenges [36] Question: Opportunities for SelectQuote in the current market - Management highlighted the company's unique capabilities and efficiency, positioning it well to capture market share amidst financial stress in the healthcare system [42][43] Question: Negotiating position with SelectRx due to scale - Management noted that the scale of SelectRx has enhanced negotiating power, allowing for deeper partnerships and better terms with PBM [58][60] Question: Incremental volume absorption at the Kansas facility - Management stated that the Kansas facility has significant capacity for expansion without requiring meaningful new capital investment [61][63]

Financial Data and Key Metrics Changes - SelectQuote reported a revenue growth of 12% year-over-year, totaling $537 million, driven by both Senior and healthcare services businesses [21][22] - Senior revenue grew 2% to $262 million, with adjusted EBITDA of $102 million, maintaining near record margins of 39% [22][23] - Healthcare services revenue increased by 26% year-over-year to $231 million, with membership growing 17% to 113,000 [24][25] - Operating cash flow for fiscal 2026 is expected to be between $25 million and $35 million, representing a significant increase compared to the previous year [30][32] Business Line Data and Key Metrics Changes - The Senior segment achieved an EBITDA margin of 39%, driven by strong marketing efficiency and agent productivity [21][22] - The healthcare services segment, particularly SelectRx, saw a 26% revenue increase, indicating strong demand and growth potential [24][25] - Life insurance revenue grew 9% to $44 million, with final expense premiums increasing by 24% [25][26] Market Data and Key Metrics Changes - The Medicare Advantage (MA) market experienced significant disruptions, with approximately 7% of plans canceled by carriers, compared to a historical average below 1% [13][14] - SelectQuote's recapture rate improved to 33%, reflecting effective customer retention strategies in a dynamic market [15][16] Company Strategy and Development Direction - SelectQuote aims to prioritize profitability and cash flow over growth, focusing on operational efficiency and strategic capital deployment [20][32] - The company has established a new $415 million credit facility, enhancing its capital flexibility and allowing for strategic investments [27][28] - SelectQuote's strategy includes leveraging its technology and data to improve service delivery and operational efficiency, particularly in the Senior segment [12][18] Management's Comments on Operating Environment and Future Outlook - Management acknowledged recent headwinds from a national carrier's marketing budget cuts, which are expected to impact fiscal 2026 by approximately $20 million [7][29] - Despite these challenges, management remains confident in the long-term growth, profitability, and cash flow potential of the business [8][29] - The company is focused on navigating the current market dynamics and believes it is well-positioned to capitalize on future opportunities [60][62] Other Important Information - SelectQuote's SelectRx service addresses inefficiencies in the medication system, contributing to improved health outcomes for seniors [18][19] - The company is committed to enhancing its negotiating position with pharmacy benefit managers (PBMs) due to its growing scale and successful engagement with complex member populations [68] Q&A Session Summary Question: Details on the PBM deal and its impact - Management highlighted the new multi-year PBM agreement provides stability and predictability, addressing the $20 million hit expected in fiscal 2026 [36][37] Question: Risks of other carriers following the marketing budget cuts - Management indicated that the decision was not unique to SelectQuote and expressed confidence in navigating through the challenges [38][39] Question: Opportunities for SelectQuote in the current market - Management emphasized the company's unique capabilities and operational efficiency, which position it well to capture market share despite current challenges [45][46] Question: SelectRx's negotiating position and scale - Management confirmed that the scale of SelectRx has enhanced its negotiating power with PBMs, allowing for deeper partnerships [68] Question: Incremental volume absorption at the Kansas facility - Management noted that the Kansas facility has significant capacity for expansion without requiring substantial new capital investments [70][71]

Financial Data and Key Metrics Changes - SelectQuote reported a revenue growth of 12% year-over-year, totaling $537 million, driven by both Senior and healthcare services businesses [20][21] - Senior revenue grew 2% to $262 million, with adjusted EBITDA of $102 million, maintaining near record margins of 39% [22][23] - Healthcare services revenue increased by 26% year-over-year to $231 million, with membership growing 17% to 113,000 [24][25] - Operating cash flow for fiscal 2026 is expected to be between $25 million and $35 million, reflecting a significant increase compared to the previous year [30][32] Business Line Data and Key Metrics Changes - The Senior segment achieved an EBITDA margin of 39%, driven by strong marketing efficiency and agent productivity [21][22] - The healthcare services segment, particularly SelectRx, saw a 26% revenue increase, indicating strong demand and growth potential [24][25] - Life insurance revenue grew 9% to $44 million, with final expense premiums increasing by 24% [25] Market Data and Key Metrics Changes - The Medicare Advantage (MA) market is experiencing volatility due to carrier plan changes and terminations, impacting growth strategies [20][22] - Approximately 7% of total plans in force have been canceled by carriers in the past two seasons, compared to a historical average below 1% [12][13] Company Strategy and Development Direction - The company aims to prioritize profitability and cash flow over growth, leveraging its diversified model to navigate market challenges [19][60] - SelectQuote's strategy includes focusing on tenured agent retention and proactive engagement with policyholders to enhance service delivery [10][14] - The new $415 million credit facility enhances capital flexibility, allowing the company to capitalize on growth opportunities when market conditions are favorable [6][19] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the long-term growth, profitability, and cash flow potential despite recent headwinds, including a $40 million aggregate impact from carrier actions [8][29] - The company remains focused on delivering high-quality service and maintaining strong customer retention rates in a challenging market environment [15][46] - Management anticipates continued dialogue with carriers regarding advance rate notices to address rising utilization and care costs [45] Other Important Information - SelectQuote's SelectRx service addresses inefficiencies in the medication system, contributing to improved health outcomes for seniors [17][18] - The company has made significant improvements in cash flow generation, with a focus on operational efficiency across both Senior and healthcare services divisions [30][32] Q&A Session Summary Question: Details on the PBM deal and its impact - Management confirmed that the new PBM arrangement provides stability and predictability, addressing the $20 million hit in fiscal 2026 as a one-time issue [35][36] Question: Risks of other carriers following the marketing budget cut pattern - Management indicated that the decision to cut marketing budgets was not unique to SelectQuote and expressed confidence in navigating through the challenges [38][39] Question: Opportunities for SelectQuote in the current market - Management highlighted the company's unique capabilities and efficiency, positioning it well to capture market share amid financial stress in the healthcare system [44][46] Question: Negotiating position with SelectRx due to scale - Management noted that the scale of SelectRx has enhanced its negotiating power, allowing for deeper partnerships and improved terms with PBM [65][66] Question: Incremental volume absorption at the Kansas facility - Management stated that the Kansas facility has significant capacity for expansion without requiring substantial new capital investment, supported by automation and technology initiatives [67][69]

2nd Quarter Fiscal 2026 Earnings Presentation February 5, 2026 | We shop. You save. Disclaimer Forward-Looking Statements This presentation contains forward-looking statements. These forward-looking statements reflect our current views with respect to, among other things, future events and our financial performance. These statements are often, but not always, made through the use of words or phrases such as "may," "should," "could," "predict," "potential," "believe," "will likely result," "expect," "continu ...

Financial Data and Key Metrics Changes - The company generated consolidated revenue of $329 million, representing a 13% growth year-over-year, primarily driven by strong growth in healthcare services [4][17] - Senior revenues declined to $59 million from $93 million a year ago, a decrease of 37%, attributed to lower policy production due to new eligibility requirements [4][18] - The company reported a quarterly EBITDA loss of $32 million, which was below the guided loss range of $25-$30 million [8][17] Business Line Data and Key Metrics Changes - The senior business segment experienced a 32% reduction in policy production compared to the previous year, leading to a negative EBITDA of $21 million [5][18] - Healthcare services EBITDA was impacted by changes in drug reimbursement rates, with an expected second-quarter adjusted EBITDA of approximately break-even [6][20] - The life insurance business saw nearly 20% revenue growth, driven by balanced growth in term life and final expense policies [22] Market Data and Key Metrics Changes - The company noted an elevated level of policyholder volatility due to shifts in planned benefits and structures from carriers, which is expected to continue in the upcoming AEP season [9][10] - The Medicare Advantage (MA) market is experiencing a high level of consumer engagement as beneficiaries evaluate options, with a focus on simplifying benefits [34][36] Company Strategy and Development Direction - The company aims to leverage its data-enabled agent-led model as a competitive advantage in the dynamic Medicare Advantage market [9][10] - There is a strategic focus on improving policyholder retention and understanding their plans better, which is seen as critical in the current environment [10][27] - The company is negotiating a longer-term reimbursement agreement with its PBM partner to enhance visibility and predictability for its healthcare services business [6][20] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the long-term economics of healthcare services despite short-term reimbursement challenges [7][20] - The company remains optimistic about the upcoming AEP and OEP seasons, supported by strong agent retention and successful preseason hiring [10][23] - The fiscal 2026 financial outlook remains unchanged at $1.65 billion to $1.75 billion in revenue and $120 million to $150 million in adjusted EBITDA [23] Other Important Information - The company is actively working on improving medication adherence through its SelectRx program, which has shown positive results in reducing hospital days and improving health outcomes [16][12] - The company is expanding its healthcare services offerings to address social determinants of health, enhancing its value proposition to members [31] Q&A Session Summary Question: Concerns about SelectRx reimbursement headwinds - Management reassured that they are in constructive discussions with their PBM partner to solidify a longer-term agreement, emphasizing the clinical value of their solution [24][25] Question: Impact of SelectRx on LTV - Management noted that while they observe improved persistency among SelectRx members, this is not currently factored into the lifetime value calculations [25][26] Question: Strategies for helping policyholders understand their plans - Management highlighted their proactive approach to assist beneficiaries in navigating plan changes, utilizing AI and data to enhance customer engagement [27][29] Question: Market dynamics in the AEP season - Management indicated that the current AEP season is dynamic, with high consumer engagement and a focus on profitability among carriers [34][36] Question: Managing growth in SelectRx - Management emphasized a measured approach to member growth, focusing on profitability and partnerships with payers that value their services [38][40]

1st Quarter Fiscal 2026 Earnings Presentation November 6, 2025 | We shop. You save. Disclaimer Forward-Looking Statements This presentation contains forward-looking statements. These forward-looking statements reflect our current views with respect to, among other things, future events and our financial performance. These statements are often, but not always, made through the use of words or phrases such as "may," "should," "could," "predict," "potential," "believe," "will likely result," "expect," "continu ...

Financial Data and Key Metrics Changes - Consolidated revenue for fiscal year 2025 reached $1.5 billion, representing a 16% increase year-over-year [5] - Adjusted EBITDA totaled $126 million, with an EBITDA margin of 8%, consistent with the previous year despite revenue growth from lower-margin healthcare services [6][26] - Healthcare Services revenue grew approximately 55% to nearly $500 million, driven by the SelectRx platform [5][11] Business Line Data and Key Metrics Changes - Senior Medicare Advantage business generated $600 million in revenue, with adjusted EBITDA of $162 million, reflecting a 200 basis point increase in EBITDA margins despite a smaller agent workforce [27] - Healthcare Services segment saw membership grow by 31%, with revenue of $743 million and adjusted EBITDA of $25 million, indicating significant progress in scale and profitability [11][30] - Life division revenues grew 10% to $173 million, with a 32% increase in adjusted EBITDA to $27 million, representing a 15% margin [31] Market Data and Key Metrics Changes - The company noted a challenging market backdrop for the Senior Medicare Advantage business due to significant plan changes by carriers and new eligibility parameters [6] - The addressable market for SelectRx is described as massive, with expectations for continued strong growth in healthcare services [30] Company Strategy and Development Direction - The company aims to leverage its information and connectivity advantage within healthcare to drive profitability and cash flow [10][14] - SelectQuote's strategic vision includes becoming a holistic solution provider across the $5 trillion U.S. healthcare market, focusing on efficiency and cash flow generation [13][22] - The company plans to balance growth with sustainable cash flows, with expectations for a flatter year in Medicare Advantage submissions [23][25] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving 20% plus EBITDA margins driven by technology and agent-led models [23] - The company anticipates generating positive operating cash flow in fiscal 2026, with a focus on capital allocation to improve the balance sheet [38] - Management highlighted the importance of technology and AI in enhancing operational efficiency and customer service [17][19] Other Important Information - The company has made significant investments in technology to automate tasks and optimize decision-making, which has improved enrollment times by 25% [20][68] - The Kansas distribution facility is expected to enhance capacity and drive margin improvements in the healthcare services segment [12][44] Q&A Session Summary Question: Can you discuss the path to target margins as SelectRx scales? - Management indicated that as the business scales, they expect to drive variable costs down and enhance margins through automation and operational refinements [40][43] Question: Is there a catalytic level of EBITDA contribution that could accelerate the securitization program? - Management noted that while there is no specific threshold, increasing EBITDA generation will open up various paths for capital structure improvements [46][47] Question: What dynamics have changed regarding SelectRx growth? - Management clarified that while membership growth may slow, they expect strong EBITDA growth due to operational refinements and partnerships with carriers [51][52] Question: How significant is AI in serving more customers? - Management highlighted that AI is used to enhance agent efficiency and improve customer interactions, resulting in significant time savings [54][66] Question: What are the capital allocation priorities moving forward? - Management emphasized the importance of balancing growth with cash flow generation, focusing on improving the capital structure while exploring growth opportunities in healthcare services [74][78]

Financial Data and Key Metrics Changes - Consolidated revenues for the third quarter reached $408 million, an 8% increase compared to the previous year [5][24] - Consolidated EBITDA totaled $38 million, maintaining healthy margins despite a shift in business mix [6][24] - The trailing twelve-month revenue to customer acquisition cost (CAC) ratio improved to 5.8x from 4.2x a year ago, indicating enhanced marketing efficiency [10][11] Business Line Data and Key Metrics Changes - Senior segment revenues totaled $169 million, with adjusted EBITDA of $46 million, resulting in a 27% EBITDA margin despite a 26% reduction in agent headcount [25][26] - Healthcare Services revenue grew 53% year-over-year to $190 million, with adjusted EBITDA of $6 million [29] - Life Insurance revenues increased by 13% to $46 million, with adjusted EBITDA more than doubling to $6 million, resulting in a 14% EBITDA margin [31] Market Data and Key Metrics Changes - The SelectRx business saw membership grow by 41% year-over-year, reaching 106,000 members [5][29] - The Medicare Advantage environment was characterized by a strong close rate despite a smaller agent force, with policies totaling 168,000, down less than 10% [12][26] Company Strategy and Development Direction - The company aims to enhance profitability in the Healthcare Services segment by refining membership parameters and focusing on efficiency [18][55] - Plans to increase agent hiring are underway to capitalize on market improvements, particularly in the Medicare Advantage space [42][43] - The opening of a new facility in Kansas is expected to drive long-term operational efficiency and margin expansion, although it may initially drag profitability [62] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism regarding the final rate notice for Medicare Advantage, which is expected to improve carrier reimbursement rates and market conditions [60] - The company anticipates potential headwinds in the fourth quarter due to new beneficiary eligibility parameters and the ramp-up of the Kansas facility [32][62] - Overall, management remains confident in the business model's ability to generate operating leverage and shareholder value [66] Other Important Information - The company is facing a Department of Justice complaint related to the Medicare Advantage system but plans to mount a vigorous defense [21][22] - Significant progress has been made on the capital structure, including a $100 million securitization and a $350 million strategic investment [34][35] Q&A Session Summary Question: Can you walk through the separation of growth in Medicare Advantage and SelectRx? - Management noted that while there was a 26% reduction in agent count, the close rates were strong due to tenured agents, which helped drive efficiency and attach rates to SelectRx [37][39] Question: What are the plans for agent growth in the upcoming season? - Hiring is currently underway, with expectations to discuss more in the upcoming guidance [42][43] Question: Can you provide insights on the receivable securitization? - Management indicated that securitization is a potential path for capital structure optimization, with several options being explored [44][45] Question: How should investors think about MA LTV moving forward? - A decline in MA LTV is expected in the fourth quarter due to the shift in commission structure, with further details to be shared in the next earnings call [49][51] Question: What benefits are expected from the new Kansas facility? - The facility is anticipated to improve operating efficiency and customer experience, although there will be a short-term drag on profitability [61][62]

Financial Performance - Revenue increased by 8% year-over-year, reaching $408.2 million in 3Q25 compared to $376.4 million in 3Q24[14] - Adjusted EBITDA decreased to $37.7 million in 3Q25 from $46.6 million in 3Q24[14] - The combined Senior and Healthcare Services Revenue-to-Customer Acquisition Cost (Rev-to-CAC) multiple was 5.8x[14] - The company anticipates full year 2025 revenue between $1500 billion and $1575 billion, representing a 16% year-over-year increase at the midpoint[38] - The company anticipates full year 2025 Adjusted EBITDA between $115 million and $140 million, representing a 9% year-over-year increase at the midpoint[38] - The company anticipates full year 2025 Net Income (Loss) between $(1) million and $28 million, representing a 140% year-over-year increase at the midpoint[38] Senior Segment - Approved Medicare Advantage (MA) policies exceeded forecasts, despite a 26% reduction in the number of agents, resulting in only a 10% decrease in MA policies[14] - Strong close rates contributed to robust performance and Adjusted EBITDA margins of 27% in 3Q25[14,17] - Total approved policies decreased from 202,000 in 3Q24 to 186,000 in 3Q25[30] - Medicare Advantage Lifetime Value (MA LTV) decreased from $995 in 3Q24 to $915 in 3Q25[30] Healthcare Services (SelectRx) - SelectRx membership grew by 41% year-over-year, reaching nearly 106,000 members in 3Q25[14,22] - SelectRx generated nearly $675 million in trailing 12-month revenue[22]